Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 7, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jasper Hellweg Upgraded (BIIB) to Strong Buy on, Oct 7th, 2022
Jasper Hellweg of Argus Research, Upgraded "Biogen Inc." (BIIB) to Strong Buy on, Oct 7th, 2022.
Jasper has made no other calls on BIIB in the last 4 months.
There are 14 other peers that have a rating on BIIB. Out of the 14 peers that are also analyzing BIIB, 4 agree with Jasper's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Chris Schott of "JP Morgan" Maintained at Hold with Increased Target to $275 on, Friday, September 30th, 2022
- Christopher Raymond of "Piper Sandler" Maintained at Hold with Increased Target to $280 on, Wednesday, September 28th, 2022
- Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $217 on, Wednesday, September 28th, 2022
- Paul Matteis of "Stifel" Maintained at Hold with Decreased Target to $223 on, Monday, September 12th, 2022
These are the ratings of the 10 analyists that currently disagree with Jasper
- Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $309 on, Thursday, October 6th, 2022
- Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $321 on, Wednesday, September 28th, 2022
- Brian Skorney of "Baird" Upgraded from Hold to Buy and Increased Target to $340 on, Wednesday, September 28th, 2022
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $350 on, Wednesday, September 28th, 2022
- Evan Seigerman of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $360 on, Wednesday, September 28th, 2022
- Salim Syed of "Mizuho" Upgraded from Hold to Strong Buy and Increased Target to $270 on, Wednesday, September 28th, 2022
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $265 on, Thursday, September 22nd, 2022
- Phil Nadeau of "Cowen & Co." Maintained at Buy with Decreased Target to $270 on, Thursday, July 21st, 2022
- Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $250 on, Thursday, July 21st, 2022
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $230 on, Monday, July 18th, 2022
